Artal Group S.A. - IKENA ONCOLOGY INC ownership

IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 43 filers reported holding IKENA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of IKENA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$8,008
-34.0%
1,849,5130.0%0.34%
-8.8%
Q2 2023$12,133
+127.0%
1,849,513
+19.4%
0.38%
+18.2%
Q1 2023$5,346
+29.7%
1,549,5130.0%0.32%
+38.3%
Q4 2022$4,122
-99.9%
1,549,5130.0%0.23%
-2.1%
Q3 2022$5,501,000
-19.9%
1,549,5130.0%0.24%
-36.0%
Q2 2022$6,864,000
-27.4%
1,549,5130.0%0.37%
-7.3%
Q1 2022$9,452,000
-51.4%
1,549,5130.0%0.40%
-24.9%
Q4 2021$19,431,000
-0.6%
1,549,5130.0%0.53%
+20.3%
Q3 2021$19,555,000
-10.1%
1,549,5130.0%0.44%
-0.9%
Q2 2021$21,755,000
-50.3%
1,549,5130.0%0.44%
-42.8%
Q1 2021$43,774,0001,549,5130.77%
Other shareholders
IKENA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,249,123$63,538,0006.01%
CHI Advisors LLC 814,756$23,017,0004.61%
Octagon Capital Advisors LP 400,000$11,300,0004.26%
BVF INC/IL 1,599,658$45,190,0001.69%
Logos Global Management LP 419,853$11,861,0001.16%
Orbimed Advisors 2,933,941$82,884,0000.78%
Artal Group S.A. 1,549,513$43,774,0000.77%
HealthCor Management, L.P. 341,212$9,639,0000.34%
RA Capital Management 750,000$21,188,0000.32%
Nantahala Capital Management 325,000$9,181,0000.27%
View complete list of IKENA ONCOLOGY INC shareholders